Novartis files reply backing dismissal of US states' antitrust claims over generic drugs
MLex Summary: Novartis AG filed a reply in support of dismissing a US antitrust case filed by a group of state attorneys general over an alleged generic drug pricing-fixing scheme, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article